VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance

Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

Leave a Reply

Your email address will not be published. Required fields are marked *